Yang Miao
Overview
Explore the profile of Yang Miao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hu Y, Zhang L, Gong Q, Huang L, Yin C, Miao Y, et al.
Front Pharmacol
. 2025 Mar;
16:1481114.
PMID: 40078281
Background: Ripretinib is a tyrosine kinase inhibitor indicated for the treatment of adult patients with advanced gastrointestinal stromal tumors (GISTs) who have previously received treatment with at least three kinase...
2.
Zhu Y, Yao Z, Li S, Ma J, Wei C, Yu D, et al.
bioRxiv
. 2025 Feb;
PMID: 39975373
Hydrogel materials have emerged as versatile platforms for various biomedical applications. Notably, the engineered nanofiber-hydrogel composite (NHC) has proven effective in mimicking the soft tissue extracellular matrix, facilitating substantial recruitment...
3.
Cheng Y, Yao Q, Miao Y, Guan W
Biochem Pharmacol
. 2025 Feb;
233:116773.
PMID: 39894309
Depression is one of the most disabling psychiatric disorders, whose pathophysiology has not been fully understood. Increasing numbers of preclinical studies have highlighted that metformin, as the first-line hypoglycaemic agent,...
4.
Gong Q, Zhang L, Wu H, Miao Y, Huang L, Yin C, et al.
Int J Clin Pharm
. 2025 Jan;
PMID: 39821007
Background: Maribavir is a novel antiviral agent targeting cytomegalovirus through inhibition of the UL97 protein kinase, exhibiting a distinct mechanism of action. However, limited data are available on its safety...
5.
Hsiao M, Miao Y, Liu Z, Schutze K, Limjunyawong N, Chien D, et al.
Mol Cell Proteomics
. 2025 Jan;
24(2):100901.
PMID: 39746545
Animal venoms, distinguished by their unique structural features and potent bioactivities, represent a vast and relatively untapped reservoir of therapeutic molecules. However, limitations associated with comprehensively constructing and expressing highly...
6.
Miao Y, Shuang W, Qianwei Q, Xin L, Wei P, Hai Y, et al.
Front Pharmacol
. 2025 Jan;
15:1413669.
PMID: 39744121
Introduction: The mechanism of tannic acid (TA) intervention on methicillin-resistant (MRSA, USA 300) biofilm formation was explored using proteomics. Methods: The minimum inhibitory concentration (MIC) of TA against the MRSA...
7.
Miao Y, Zhao F, Guan W
Int J Neuropsychopharmacol
. 2024 Dec;
28(2).
PMID: 39657242
Background: Depression is a prevalent and disabling disorder that poses serious problems in mental health care, and rapid antidepressants are novel treatments for this disorder. Cannabidiol (CBD), a nonintoxicating phytocannabinoid,...
8.
Wu X, Zhang L, Tong Y, Ren L, Guo H, Miao Y, et al.
ACS Nano
. 2024 Oct;
18(43):29558-29571.
PMID: 39427259
Magnetic liquid-bodied microrobots (MRs) possess nearly infinite shape adaptivity. However, they currently confront the risk of structure instability/crushes during shape-morphing in tiny biological environments. This article reports that magnetic liquid...
9.
Du X, Yang W, Nosenko V, Miao Y, Li W, Yu J, et al.
Soft Matter
. 2024 Sep;
20(37):7362-7366.
PMID: 39268683
Complex plasmas consist of ionized gas and charged solid microparticles, representing the plasma state of soft matter. We apply machine learning methods to investigate a melting transition in a two-dimensional...
10.
Wei X, Zhao Y, Yan W, Dai Q, Wu H, Miao Y, et al.
Onco Targets Ther
. 2024 Aug;
17:629-642.
PMID: 39131903
Background: Anlotinib and apatinib, both vascular endothelial growth factor receptor-tyrosine kinase inhibitors (VEGFR-TKIs), are clinically established in the treatment of advanced non-small cell lung cancer (NSCLC) in China, with anlotinib...